Ping An Biomedical Co., Ltd. PASW
0.13
0.00
0.00%
as of 25 Sep
- Market cap
- $16.2M
- P/E
- —
Follow PASW
| Sep '24 | Mar '25 | Sep '25 | Mar '26 | |
|---|---|---|---|---|
Current Ratio |
0.84 | 0.77 | 2.76 | 2.54 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
18.40% | 21.16% | 14.76% | 9.98% |
Debt/Equity |
(1.46) | (0.88) | 0.22 | 0.13 |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
2.09 | 0.03 | (0.90) | 0.16 |
Working Capital |
(1.46) | (1.93) | 5.71 | 4.91 |
Capital Expenditures |
0.00 | — | 0.00 | — |
Net Current Asset Value |
(1.53) | (1.97) | 5.69 | 4.91 |
| Other line items | ||||
Quick Ratio |
0.64 | 0.54 | 2.32 | 1.91 |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Capex per Share |
0.00 | — | 0.00 | — |
Capex to Sales |
0.00 | — | 0.00 | — |
Columns are period end dates